MAPT and Alzheimer disease: In fact, it has been recently demonstrated in different AD mouse models that SIRT2 genetic deletion or pharmacological inhibition improves learning and memory, restores alterations in long-term potentiation, and reduces amyloid and tau pathology and neuroinflammation [65,66,71,72,73].